Previous 10 | Next 10 |
Anika Therapeutics, Inc. (ANIK) Q1 2022 Earnings Conference Call May 05, 2022, 05:00 PM ET Company Participants Mark Namaroff - VP, IR, ESG and Corporate Communications Cheryl Blanchard - President and CEO Mike Levitz - EVP, CFO and Treasurer Conference Call Participants Chris Cooley - Stephe...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Anika Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation
Anika Therapeutics press release (NASDAQ:ANIK): Q1 Non-GAAP EPS of -$0.11 beats by $0.20. Revenue of $36.69M (+7.0% Y/Y) beats by $3.76M. The company expects its overall revenue for fiscal year 2022 to be toward the upper end of its guidance range of low to mid-single digit percent growth com...
BEDFORD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its first quarter ended March 31, 2022. First Quarter 2022 Financial Summary ...
BEDFORD, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2022 financial results after the close of the market on Th...
BEDFORD, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 21st Annual Needham Virtual Healthcare Conference on Thursday, April...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event. For further details see: Anika Therapeutics (ANIK) Presents at the Canaccord Genuity Musculoskeletal Conference - Slideshow
BEDFORD, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it will showcase its comprehensive joint preservation and restoration product portfolio at the 2022 American Academy of Orthopedic Surgeons (A...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Anika Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation
Anika Therapeutics' share price is being punished by the market owing to some possibly over-ambitious growth projections made in June last year. Management believed it could nearly double revenues, to $230m, by 2024, but after a so-so 2021, these plans have been abandoned. Anika i...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company in early interven...
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2024 financial results after the close of the market on Wednesda...
2024-04-09 16:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...